Letter by Schmidt et al Regarding Article, "Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study"
- PMID: 36944034
- DOI: 10.1161/CIRCULATIONAHA.122.062745
Letter by Schmidt et al Regarding Article, "Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study"
Comment on
-
Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study.Circulation. 2022 Sep 27;146(13):995-1005. doi: 10.1161/CIRCULATIONAHA.122.059430. Epub 2022 Aug 25. Circulation. 2022. PMID: 36004644 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
